Analytical Data
-
基因名
LDOC1L
- Application
-
别名
dJ1033E15.2; DKFZp761O17121; LDOC1L; LDOCL_HUMAN; Leucine zipper down regulated in cancer 1 like; Leucine zipper protein down-regulated in cancer cells-like; Mammalian retrotransposon derived protein 6
-
种属
Human
-
表达系统
E. coli
-
标签
GST-tag at N-terminal
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q6ICC9
-
表达区间
1-239aa
-
氨基酸序列
MGSSHHHHHHSSGLVPRGSHMGSHMVQPQTSKAESPALAASPNAQMDDVIDTLTSLRLTNSALRREASTLRAEKANLTNMLESVMAELTLLRTRARIPGALQITPPISSITSNGTRPMTTPPTSLPEPFSGDPGRLAGFLMQMDRFMIFQASRFPGEAERVAFLVSRLTGEAEKWAIPHMQPDSPLRNNYQGFLAELRRTYKSPLRHARRAQIRKTSASNRAVRERQMLCRQLASAGTGPCPVHPASNGTSPAPALPARARNL
-
分子量
28.7 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
LDOC1L, or LDOC1-like protein, is a recently identified member of the LDOC1 family of proteins, which play crucial roles in various cellular processes, including cell signaling and immune responses. Research into LDOC1L is driven by its potential implications in human health, particularly in relation to cancer and inflammatory diseases. Recent studies have suggested that LDOC1L may be involved in modulating key signaling pathways, such as those governing apoptosis and cell proliferation. Its expression levels have been correlated with tumor progression in several types of cancers, indicating its possible utility as a biomarker or therapeutic target. Furthermore, LDOC1L's role in immune cell regulation highlights its significance in understanding autoimmune conditions. Investigating the biochemical properties and functions of LDOC1L through recombinant protein techniques can provide insights into its mechanisms of action and interactions with other cellular proteins. This research holds promise for developing novel treatment strategies that harness the capability of LDOC1L in modulating disease pathways. Understanding LDOC1L's structure and function could pave the way for innovative approaches in targeted therapies and personalized medicine.
